Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 27Gastrointestinal 12Breast 10Thoracic 7Other hematologic neoplasm 4Head & Neck 4Myeloid 3Lymphoid 3Sarcoma 2Gynecologic 2Dermatologic 2CNS 2Plasma cell 1Other solid neoplasm 1Genitourinary 1Endocrine 1Classical hematology 1

Conditions

Advanced Solid Tumors 483Solid Tumor 446Advanced Solid Tumor 414Unspecified Adult Solid Tumor, Protocol Specific 362Solid Tumors 336Mesothelioma, Malignant 324Mesothelioma 289Solid Tumor, Adult 124Carcinoma, Non-Small-Cell Lung 122Retinoblastoma 117Lung Neoplasms 77Ovarian Neoplasms 75Melanoma 65Sarcoma 62Carcinoma, Renal Cell 59Stomach Neoplasms 58Pancreatic Neoplasms 58Neoplasms 53Esophageal Neoplasms 53Small Cell Lung Carcinoma 52Colorectal Neoplasms 52Hematopoietic and Lymphatic System Neoplasm 50Uterine Cervical Neoplasms 46Breast Neoplasms 46Solid Tumours 35Neoplasm Metastasis 35Advanced or Metastatic Solid Tumors 35Squamous Cell Carcinoma of Head and Neck 34Carcinoma, Hepatocellular 32Triple Negative Breast Neoplasms 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Second Primary × Other solid neoplasm × Clear all
NCT00342797 2024-03-07

Retinoblastoma Biomarker Study

National Institutes of Health Clinical Center (CC)

Completed
2,136 enrolled
DermatologicOther solid neoplasmSarcoma

Melanoma, Retinoblastoma, Sarcoma, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡